We found that either cyclin D1 or CDK4 could not only reverse the inhibitory phenotype produced by Tspan5 but also promote the cell growth further as compared to the basal control, suggesting that cyclin D1/CDK4 have a dominant role in mediating the suppression of tumour growth by Tspan5 in GC. Here, CDK4 is linked to gastric cancer.